Shri Ahimsa Naturals Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹19.5(16.39%)
Premium (ELP)
Shri Ahimsa Naturals Limited's successfully completed its Initial Public Offering and commenced trading on Apr 02, 2025 at the NSE exchange. The company raised 62,02,800 Shares through this public offering, comprising 42,03,600 Shares in fresh capital and ₹23.79 Cr through the Offer for Sale mechanism.
The IPO was priced within the band of ₹113 to ₹119, with minimum application lots of 1200 shares. The offering attracted significant investor interest during its subscription period from Mar 25, 2025 to Mar 27, 2025.
Share allotment was finalized on Mar 28, 2025, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Shri Ahimsa Naturals Limited has been around since 1990, specializing in extracting and producing Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine. They also trade in other herbal extracts. Their products are widely used in industries like food & beverages, nutraceuticals, cosmetics, and pharmaceuticals, thanks to their various health benefits. The company offers Natural Caffeine, sourced from coffee and tea seeds, which is commonly found in energy drinks, soft drinks, cosmetics, and medicines. They also produce Green Coffee Bean Extract, made from unroasted coffee seeds, known for its antioxidant properties and potential weight management benefits. Shri Ahimsa Naturals exports to several countries, including the USA, Germany, South Korea, the UK, and Thailand. For the period ending September 30, 2024, they reported export revenues of ₹3,530.91 lakhs. In previous years, exports reached ₹7,463.71 lakhs in Fiscal 2023, ₹5,633.50 lakhs in Fiscal 2022, and ₹9,988.01 lakhs in their highest fiscal year. Their manufacturing facility in Jaipur, Rajasthan, follows top global standards like ISO 9001:2015, ISO 22000:2018, ISO 45001:2018, ISO 14001:2015, HACCP, and GMP, ensuring high-quality production. As of March 2025, the company had around 80 employees.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Expert Leadership – Guided by seasoned professionals, fostering growth and innovation.
- Cutting-Edge Manufacturing & R&D – Modern facility in Jaipur, delivering high-quality products.
- Trusted Global Partnerships – Long-standing relationships across food & beverage, nutraceuticals, cosmetics, and pharmaceuticals.
- Project Execution Challenges – The ₹3,500 lakh investment in Shri Ahimsa Healthcare Private Limited’s new manufacturing unit may face delays, budget overruns, and regulatory dependencies, potentially impacting operations and financial stability.
- Audit Observations – Statutory Auditors have highlighted certain qualifications in audit reports for the half-year ending September 30, 2024, and fiscal years 2024, 2023, and 2022, which could raise concerns about financial compliance and transparency.
- Supply Chain & Vendor Risks – Delays in acquiring machinery, equipment, or completing construction work for the new unit could hinder expansion, increase costs, and affect overall operations.
- Mr Nemi Chand Jain
- Mrs Sumitra Jain
- Mr Amit Kumar Jain
- Mr Sumit Jain
- Mrs Prerna Jain
- M/s Ahimsa Holdings Private Limited
- M/s Bimneer Investments Private Limited.
Shri Ahimsa Naturals Limited
Cameo Corporate Services Limited